glp-1 psychiatric side effects Prospects of Therapies for Addiction and Mental Health Comorbidities-Quo Vadis?: A Review Managing Side Effects of GLP-1

Not Zepbound specifically Zepbound is only FDA-approved for weight management and sleep apnea

and B.T

This variability makes it difficult to study and even harder to generalize, which is an important limitation to keep in mind

Patients using semaglutide often report: Reduced appetite and fewer food cravings Improved portion control Gradual, steady weight loss over time Semaglutide has been studied extensively and has a strong safety and efficacy profile

Research 13 also indicates that GLP-1 medications reduce the activation of appetite- and reward-related brain regions, such as the insula and amygdala, thereby reducing food intake

More than 30 million Americans have tried one of these GLP-1 agonist drugs